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Genetic Anomalies in Mammalian Germ Cells
and Their Significance for Human
Reproductive and Developmental Risk
by Vicki L. Dellarco
The induction of heritable mutations in germ cells represents a potential health concern. This paper
highlights data from mouse germ-cell mutagenesis studies that have implications in the assessment of
reproductive and developmental risks. The paper discusses the developmental and reproductive consequences
of induced chromosomal damage (structural rearrangements and numerical anomalies) and describes
environmental agentsthathavebeen showntoproducesuchanomalies.Additionally, factorsthatinfluencethe
yield of genetic damage are addressed. Studies showing that the various germ-cell stages vary in their
susceptibility to the induction of genetic damage are summarized. Of the chemicals evaluated in the male
mouse, most appear to have their predominant or strongest effect on post-stem-cell stages. The differences
between males and females in the susceptibility to mutagens is examined. Recent studies have shown thatthe
female may be uniquely sensitive to certain mutagens. Finally, an important aspect ofmutagenic risk is not
only effects induced in developing germ cells but also the effects ofenvironimental agents during the period
from fertilization through the zygote and the two-cell embryo. Recent work in the mouse has demonstrated
that exposure duringthese early developmental stages leads to high frequencies ofexternal andvisceral fetal
malformations, as well as mid-to-late gestational death.
Introduction
Environmental exposure of the human population to
DNA- and chromosome-damaging agents is an important
toxicological problem. Mutagens may contribute to
somatic-cell diseases, such as cancer, or may cause an
increased incidence of genetic diseases in future genera-
tions. Because genetic damage in germ cells can lead to
reproductive impairment and developmental anomalies,
knowledge ofinduced germ-cell mutagenesisisrelevantto
the assessment of reproductive and developmental haz-
ards in humans from exposure to environmental contami-
nants.
No environmental agent, including radiation, has been
shown to produce heritable germ-line mutations in
humans. The lack ofhuman evidence relates to the rarity
of gene mutations, the small fraction ofhuman genes that
are currently useful as markers in estimating germ-cell
mutation, human genetic variability, small numbers of
offspring, and long generation times. Further, only disor-
ders caused by dominant mutations, some sex-linked
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recessive disorders, and chromosome-based disorders can
be detected in the first generation after their occurrence.
Manyhuman diseases are inherited (1), and itis generally
recognized that most newly appearing mutations that are
phenotypically expressed are in someways deleterious (2).
Alarge number ofsynthetic chemicals have been found to
inducegeneticdamagethatistransmittedtotheoffspring
oflaboratory animals, primarily the mouse (3). This is the
mostimportantjustification forthe concern that chemical
mutagens maycontribute to the genetic disease burden in
humans.
Assessment of genetic risk and the possible reproduc-
tive and developmental consequences to humans from
exposures to environmental mutagens requires accurate
identification and quantification in experimental systems
ofthe types ofgenetic damagethat canbeproduced inthe
germ line and transmitted to the conceptus. The types of
damage considered in genetic risk assessment are gene
mutations (dominant, semidominant, and recessive), small
deletions, structural chromosomal anomalies (reciprocal
translocations, inversions, duplications, etc.), and numeri-
cal chromosomal anomalies (whole chromosomes missing
or in excess).
This paper is not intended to be a complete review but
instead considers certain aspects ofgerm-cell mutagene-
sis that have implications in the assessment ofreproduc-
tive and developmental hazards associated with exposure
to environmental agents. This paper focuses on severalV L. DELLARCO
topics: a) the impact of induced chromosomal damage
(structural rearrangements and numerical anomalies), b)
the relative susceptibility ofthe various germ-cell stages
to the induction of heritable or transmissible genetic
damage, c) gender differences in the susceptibility to
mutagens, and d) developmental responses ofzygotes and
early cleavage embryos to mutagenic exposures.
Chromosomal Anomalies Are
Associated with Reproductive and
Developmental Defects
Chromosomal anomalies constitute a significant medi-
cal problem, and thus the chromosomal constitution of
human germ cells is of intense interest in such fields as
genetics andmutagenesis, epidemiology,humanreproduc-
tion and development, and health risk assessment. Ap-
proximately 1 in 200 live births has a detectable major
structural ornumerical chromosomal disorder (4). Down's
syndrome (trisomy 21), for example, is the most common
chromosome anomalyamonglivebirths: itis atleasttwice
as common as the single-gene trait cystic fibrosis, and 20
times more common than the single gene traits muscular
dystrophy or phenylketonuria. Chromosomal anomalies
are, in fact, more common in human beings than in any
other species (5). They form the largest known cause of
first trimester loss. The basis for this high frequency is
unclear.
Numerical Chromosome Anomalies
Abnormal chromosome numbers (heteroploidy) is an
important genetic hazard tohumans (6-8). More than 70%
of the chromosomal errors associated with early spon-
taneous abortion and nearly half of all those detected
amongnewborns are aneuploids [i.e., chromosome number
is not an exact multiple ofthe basic number in the genome
(4,7)].Additionally, polyploidy (chromosome stateinwhich
allchromosomes arerepresented morethantwice),partic-
ularly triploidy, is also common in humans, with an esti-
mated frequency of26% in aborted fetuses (7). Given the
social and financial burdens posed bythe consequences of
numerical chromosome errorsinhumanbeings, itisunfor-
tunate thatthereasons forthe humanincidence ofhetero-
ploidy and the mechanisms by which it arises remain
mostlyunknown. Itisalsounfortunatethatrelativelylittle
testing has been accomplished to detect the ability of
environmental agents toinduceheteroploidy (9) compared
to other genotoxic end points (e.g., gene mutation and
chromosomal breakage).
The absence of sufficient data on chemically induced
heteroploidy inmammalian germ cells is due to the lack of
dependable andreliable testapproaches. Inrodents,inves-
tigatorshavereliedmostlyoncytogeneticanalysis ofgerm
cells to determine aneuploidy at the gametic level. The
utility ofcytogenetic analysis maybeincreased byseveral
molecular cytogenetic approaches underdevelopmentthat
may allow for a more reliable and rapid method ofdetect-
ing germ-line aneuploidy than is now possible through
conventional cytogenetic analysis. For example, the local-
ization of kinetochores in micronucleated cells using
immunofluorescent-kinetochore staining has been devel-
oped for identifying aneuploidy-inducing agents in
cultured somatic cells (10). This approach isbeingpursued
in mouse spermatids (11). Additionally, the technique of
fluorescent in situ hybridization using DNA probes is a
promising approach that may have application for detect-
ing aneuploidy in both human and rodent germ cells
(12,13).
Both ionizing radiation and chemicals have been shown
toincreaseaneuploidyinmammals (6). Radiationprobably
causes aneuploidy by breaking chromosomes. Chemicals
also may act in this manner. Alternatively, chemicals may
also act on the spindle or the segregation process. It is
widely held that chromosome pairing, synapsis, and
crossing over are important events fornormal disjunction
and segregation and that aberrant synapsis/recombina-
tion could lead to aneuploidy (14-16). For example, studies
in Drosophila (17), mice (18), and humans with trisomy 21
(19) imply that a low level of recombination results in
chromosomal nondisjunction.
Because ofthe substantial contribution ofaneuploidyto
human infertility, reproductive failure, and congenital
malformation, there is a clear need to study the mecha-
nisms of aneuploidy production and transmission in
experimental mammals and to understand how and to
what extent aneugenic agents exert their effect on mam-
malian speciesincludinghumans.Anunderstandingofthe
basic mechanisms and components involved in chromoso-
malsegregationisessentialforunderstandinghowchemi-
cals might interfere with this process.
Chromosomal Rearrangements
Physical rearrangements of the genetic material can
lead to profound biological consequences. Rearranged
chromosomes can give rise to abnormal meiotic chromo-
some pairing, which in turn can lead to infertility or low
fertility. Structural rearrangements, particularlyrecipro-
cal translocations, have been associated with infertility,
low fertility, or spontaneous abortion (20,21). In both
humans and mice, carriers of translocations have been
associatedwithdevelopmental effects such asneurological
and skeletal disorders (22-24). Forexample, amale trans-
locationcarrierthatshoweddistinctiveneurologicalsymp-
toms was found among the offspring ofmale mice treated
with themutagentriethylenemelamine (22). Although car-
riers of balanced translocations (i.e., no genetic material
has been lost or added through the rearrangement) may
appear phenotypically normal with the exception of some
effect on fertility, they may produce offspring with devel-
opmental abnormalities. The genetic burden and medical
consequences of this aneuploidy is increased due to the
transmissibility of the aneuploidy to subsequent genera-
tions.
The developmental consequences of chromosome
imbalance produced by translocations in the mouse have
been recognized for over 50 years (25). These imbalances
arethe result oftranslocatedchromosomesgoingthrough
meiotic segregation and producing gametes with unbal-
6GENETIC EFFECTS IN GERM CELLS
anced chromosomal constitutions. Several translocation
mouse stocks have been studied, and a number ofspecific
malformations have been identified (26). In arecent study
by Rutledge et al. (27), for example, a high incidence of
developmental anomalies, such as exencephaly and cleft
palate, was found among fetuses sired by carriers of
translocations who appeared phenotypically normal
exceptfor semisterility. Thesemale translocation carriers
were derived from male mice treated with the mutagen
methylenebisacrylamide. In the offspring of these car-
riers, some ofthe malformations observed in the concep-
tuseswere associatedwithspecific duplication deficiencies
caused by the segregation of the translocated chromo-
somes. Studyofthereproductive consequences ofmultiple
stocks with induced balanced translocations revealed that
17% ofstocks had excess phenotypic anomalies analogous
to liveborn humanswithbirth defects and 42% had excess
late gestational deaths (which would equate in humans to
excess mid-pregnancy and third trimester miscarriages
and their attendant morbidity). In humans, it has been
observed that carriers ofbalanced translocations may be
at risk ofhaving chromosomally unbalanced children that
are congenitallymalformed andmentallyretarded (28,29).
More than adozen chemicals havebeen shown toinduce
transmissible translocations in the mouse (3,30). Most of
these studies have been conducted in the male. Several of
the chemicals shown to cause heritable translocations are
of environmental interest. For example, mouse heritable
translocation data on ethylene oxide, which is used as a
sterilant, fumigant, and as an intermediate in the produc-
tion of other chemicals, has been used as a model for
quantifying risks to the human germ line (31). Inhalation
exposure to ethylene oxide produced high frequencies of
heritable translocations in male mice with a steep non-
linear dose-response curve (32). Ethylene oxide also
induces gene mutations (i.e., dominant visible and elec-
trophoretic) in germ cells (33). Acrylamide, meth-
ylenebisacrylamide, ethylenebisacrylamide, and other
industrial chemicals, have been shown to induce heritable
translocations (3,27,34). Additionally, several chemo-
therapeutic agents, such as cyclophosphamide, chloram-
bucil, mitomycin C, procarbazine, and triethylene-
melamine, have been shown to induce translocations and
specific locus mutations (3).
Germ-Cell Stages Vary in Their
Susceptibility to the Induction of
Transmissible Genetic Damage
Chemicals show differences in susceptibility ofvarious
spermatogenic stages totheinduction ofheritabledamage
(35,36). Of the chemicals evaluated to date, all appear to
have their predominant or strongest effect on post-stem-
cell stages (i.e., spermatocytes, spermatids, spermatozoa)
in producing transmitted germ-line translocations
(30,32,34). Unlike radiation, no stem-cell induced effects
have been identified in the mouse dominant lethal or
heritable translocation test [(38); W. M. Generoso, per-
sonal communication]. For induced specific-locus muta-
tions, chemicals have been found to affect both stem cells
and post-stem-cell stages (36).
Althoughrisktoagentsinducingpost-stem-cell damage
would be a function only of recent exposure (because of
their relatively short life span) and should recede upon
termination of exposure, many human exposures are
repeated or continuous in both industry and the environ-
ment. Thus,heritable damageinducedinpost-stemcellsis
important for the estimation of genetic hazards. In
instances, however, inwhich exposure is not continuous or
repeated, it maybe possible to greatly reduce the genetic
hazard by avoiding conception for a designated time after
exposure. Unlike post-stem cells, damageinduced in stem
cells would become permanent sources of mutation- or
translocation-bearing sperm, and such damage would
accumulate throughout the exposure history of the indi-
vidual. The affected individual would be at some level of
increased risk for his entire reproductive life even after
exposure had ceased. The sensitivity of male germ-cell
stages to environmental mutagens and the application of
this information has been illustrated recently in a quan-
titative estimation of genetic risk associated with the
inductionofheritabletranslocationsbyethylene oxide(31).
Unlike the male, little is known about the sensitivity of
femalegerm-cell stagestoenvironmentalmutagens. Radi-
ation studies indicate differential susceptibility of the
newborn mouse ovary to cell killing and mutation induc-
tion, which is in various stages ofprophase ofmeiosis, to
that of the adult, which contains oocytes in follicles of
varying degrees ofmaturity (37). For both radiation and
chemicals, it appears that there is differential suscep-
tibility of ovarian follicles at various stages (39,40). Fur-
ther, it is clear from what information exists on mutation
induction that there are differences in the sensitivity
between female and male germ cells. The importance of
female germ-cell mutagenesis studies will be described in
the next section.
Female and Male Mice Respond
Differently to Mutagenic Agents
Because of the difficulties encountered in studying
effects in mutagen-treated female mice (e.g., toxic effects
on pregnancy, breeding problems), little information is
available on the induction of genetic damage. Because of
the differences in male and female gametogenesis (e.g.,
cellular morphology, cellular kinetics, biochemistry, chro-
matin structure), the male is unlikely to be a reliable
surrogateforpredictingfemalegeneticriskto aparticular
agent. Recentdominantlethalstudiesindicatethatcertain
chemicals can onlybe detected asmutagenic in the female
but not in the male (40-42).
The mutagens platinol, adriamycin, hyeanthone, and
bleomycin appear to induce dominant lethal mutations
onlyin female mice (40-42). Bleomycin caused the strong-
est response, producing up to 90% dominant lethals at
aboutone-fifth ofthemaximum-tolerated dose (10mg/kg).
The magnitude of response observed with bleomycin is
greater than that observed with other agents, including
ionizing radiation.
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Interpretation of results from genotoxicity testing in
the female can be complicated by the need to distinguish
between embryonic death caused directly by genetic
effects ofthe chemical on the oocytes and embryonic loss
resulting indirectly from maternal toxicity. It is thought
thatthese dominantlethal effects arethe result ofgenetic
damage and not of maternal toxicity because reciprocal
zygote transfer experiments with adriamycin and platinol
were indicative of genetic damage to the oocytes (41).
Furthermore, chromosomal aberrations were observed at
thefirstcleavageofzygotesobtainedfromfemalestreated
with adriamycin, platinol, bleomycin, and hycanthone (40-
42).
Although these agents have no detectable dominant
lethal effects inmales, itshould notbe assumedthatthese
agents are inactive in causinggenetic damage inthemale.
Bleomycin reportedly induces low levels of chromosomal
damage in spermatocytes (43) and in spermatogonia in
male mice (44-46). So although no dominant lethal muta-
tions are detected inthemale, there stillmaybe alowlevel
of damage being induced. Nevertheless, these data still
indicate that the female is at a much higher level of risk
than the male.
Sudmanetal. (40) suggestedthatthe stateofchromatin
condensation in the germ cells of female mice may be
involved in the increased vulnerability to these mutagens.
The majority of germ cells in adult female mice are
arrested in the dictyate (diffuse diplotene) stage of
meiosisinwhichthechromatinisinadiffusestate,whilein
adult males all stages of spermatogenesis are present
simultaneously, and the chromatin in most germ-cell
stages is generallymore condensed (47). The diffuse state
ofchromosomes intherestingdictyate oocyte stagewould
allow intercalation between base pairs and alkylation of
bases to occur, whereas the more condensed state of
chromatin in male germ cells may impede the interaction
of these agents with DNA. It is generally agreed that
adriamycin and hycanthone are intercalating agents (48).
It is postulated that bleomycin acts as an intercalator
(49,50). On the other hand, in the case of platinol (a
bifunctional alkylating agent), it was postulated that spe-
cific base sequences, which are preferential targets, are
more accessible for DNA biding in the female chromatin
than in the male chromatin (41). There are other pos-
sibilities that may contribute to the increased suscep-
tibility of the female compared to the male such as
differences inthetransportandmetabolismoftheagentin
male as opposed to female gonads.
In summary, results of studies that demonstrate the
existence of agents that pose a greater genetic hazard to
female mice than to male mice emphasize the importance
of developing female models to evaluate genetic/
reproductive/developmental risk from exposure to
environmental agents. In developingthesemodels, several
questions needtobeaddressed. Whatclasses ofchemicals
produce female-specific responses? What is the underly-
ingbasisfortheincreasedvulnerabilityoftheoocyte?The
mechanism involved mustbe a result ofproperties unique
to female gametogenesis. The relationship of chromatin
condensation and DNAbinding in male and female mouse
germ cells would provide some understanding regarding
the plausibility of this hypothesis concerning chromatin
condensation and susceptibility to DNA damage. Studies
addressingthe etiologyandmechanisms involvedin these
effects will contribute to the development of approaches
for characterizing female gametic risk associated with
exposure to mutagens.
Developmental Anomalies Arise from
Mutagen Treatment of Zygotes and
Early Cleavage Embryos in the Mouse
In addition to evaluating risk associated with exposure
todevelopinggermcells,animportantaspectofmutagenic
risk is the effects of environmental mutagens during the
period from fertilization through early zygotic and cleav-
age stages. Although itisgenerallybelievedthatexposure
of the one-cell zygote and early cleavage stages to a
mutagen can result in death ofthe zygote or no response,
recent studies have clearly demonstrated that mutagen
exposure during early embryogenesis can result in other
manifestations ofdevelopmental toxicityaswell asmalfor-
mations.
Mouse studies conducted at the Oak Ridge National
Laboratory(OakRidge,Tennessee)haveshownthatexpo-
sureofzygotestocertainchemicalmutagensleadstohigh
frequencies of external and visceral fetal malformations,
as well as late-gestational death (51-55; Kimmel et al., in
preparation). The fetal malformations induced generally
bear close resemblance to common sporadic human birth
defects that are ofunknown etiology. Most ofthe chemi-
cals evaluated to date have been alkylating mutagens.
Some of these agents (e.g., ethylene oxide, ethyl meth-
anesulfonate, diethylsulfate, dimethylsulfate, and
mitomycin C) were found to produceboth fetal malforma-
tion and mid- to late-gestational death, while others (e.g.,
chlorambucil, acrylamide, methylmethane sulfonate, eth-
ylnitrosourea, triethylenemelamine) only elicited an
increase in malformations (51,52,55). This suggests that
the type ofmechanisms thatlead to various types offetal
anomalies may differ from one mutagen to another. In
general, the period of vulnerability to these short-lived
mutagens appearstobeginapproximatelyaroundthetime
of sperm penetration, with the most pronounced effect
occurring near the earlypronuclear stage and disappear-
ing by the first cleavage stage. The temporal effects of
these mutagens suggest different mechanisms for the
induced fetal death and malformation but do not neces-
sarily imply a conventional mutational mechanism (dis-
cussed later). Transplantation experiments involving
reciprocal transfer of pronuclear zygotes within hours
aftertreatmentwith ethylmethane sulfonate suggestthat
maternal toxicity is not a factor in producing dysmorphic
fetuses (41).
Among the alkylating agents evaluated, ethylene oxide
(EtO) has been the most studied. Recently, the dose-
response relationship between early zygotic exposure to
EtO and prenatal development was evaluated (Kimmel et
al.,inpreparation). Sixhours aftermating,female (C3H x
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C57BL)F1 mice were exposed to several doses ofinhaled
EtO (1200, 900, or 600ppm) for aduration of1.5 hr.Ahigh
incidence of mid- and late-gestational deaths and malfor-
mations were induced atthe two highest concentrations of
EtO. The malformations observed included limb defects,
cleftpalate, abdominal wall defects, hydrops, exencephaly,
eye defects, and growth retardation. The effect ofEtO on
skeletal development was evaluated at the 1200, 900, and
600 ppm doses. EtO was found to significantly reduce the
degree ofossification intreated offspringinadose-related
manner and increase the incidence of skeletal variants,
particularlyinthesternalandcervicalregions, aspectrum
of skeletal anomalies differing from treatment during
organogenesis (54). The lowest exposure ofEtO, 600 ppm,
did notelicit an apparent differencefromthecontrolinthe
incidence ofdeathandmalformation (externalandvisceral
effects). The slope of the dose-response curve for EtO
under the above exposure scenario appears steep and
implies an apparent threshold ofresponse.
Although the basis for mutagen-induced zygote
responses is not known, current data suggest multiple
mechanisms. Inthe case ofethylnitrosourea (ENU), there
is evidence that gene mutations might be a factor for the
observed induced fetal anomalies. Russell et al. (56) found
thatearlyzygote stagesinthemousewere sensitive tothe
ENU induction ofspecific locus mutations. The frequency
ofspecific-locus mutants resulting from exposure ofearly
zygote stages was about 7-fold higher than the mutant
frequency that occurred as a result of spermatogonial
stem-cell exposuretoENU. ENUexposure ofearlymouse
zygotes also induces a high frequency of transmitted
skeletal anomalies (57). These results raise the concern
that early-stage zygotes may be at higher risk to certain
mutagens than developing germ cells. Interestingly, Rus-
sell and Bangham (58) found thatthe maternal genome in
the mouse zygote (near sperm entry and earlypronuclear
stages) is more sensitive to ENU mutagenesis than the
paternalgenome. Thebasisforthis differenceisunknown.
For EtO and ethyl methanesulfonate (EMS), the induced
malformations do not appear to be attributable to chro-
mosomal rearrangements, small deletions, or gene muta-
tions (59). Conventional mutagenicmechanisms, therefore,
are notsufficientinexplainingthe EtO-and EMS-induced
effects.
Recent studies conductedbyGeneroso (60) onthechem-
otherapeutic agent5-azacytidine suggest adifferentmode
of action postulated for the alkylating agents. Unlike the
alkylatingmutagens, such as EMS and EtO, the response
for malformation significantly increased when exposure
was 25 hr after mating. In the mouse this would corres-
pond to approximately thetimewhenembryonic genes are
beginningtobeswitchedon(61). Fromthesedata,itcanbe
speculated that induced fetal maldevelopment may also
occur as the result ofinduced epigenetic changes in early
zygote stages (e.g., disruptions in the finely tuned pro-
gram of gene expression that influences early embryonic
development). Azacytidine is a nucleoside analog that can
selectively activate eukaryotic gene expression. It is
thought to act by inhibiting enzymes that methylate
cytosine residues in eukaryotic DNA (62).
In summary, an important aspect of germ-cell muta-
genesis in producing adverse reproductive and develop-
mental effects includes exposures not only during critical
periods of gametogenesis but also near fertilization and
during early developmental stages, thus extending the
temporal period of susceptibility and raising the impor-
tant possibility of new mechanisms by which mutagenic
agents interfere with development. The similarity of the
phenotypic consequences further suggests that some of
the mechanisms may be associated with the largest
etiologic group ofhuman developmental anomalies.
Concluding Remarks
This paperhas attempted topoint out several themes in
the area of germ-cell mutagenesis that have important
implications for reproductive and developmental toxicol-
ogy. Because of the impact of genetic damage on normal
reproduction and development, testing should be pursued
toidentifygerm-cell mutagens, clastogens, and aneugens.
Although chromosomal anomalies play an important role
in producing developmental defects, the mechanistic basis
for the vast majority of human developmental defects
remains unknown. The observations of zygote-derived
developmental anomalies in mutagen-exposed pregnant
mice is ofmajorinterest in chemical safety evaluation and
in studying the etiology of congenital abnormalities. Not
only do these observations raise concerns regarding the
vulnerability of human zygotes and early-cleavage em-
bryos ofmothers exposed to environmental chemicals, but
research defining the biological factors that affect the
induction ofzygote-derived developmental anomalies may
prove helpful in understanding the large group of fetal
malformations in humans for which the etiology is still
unknown. Genetic hazards associatedwith mutagen expo-
sure to females cannot be neglected in light of recent
findings of female-specific responses in the dominant
lethal test. Finally, although defined windows of suscep-
tibility to induced genetic damage have been observed in
experimental studies, if human exposures are continuous
or repeated, it is likely that there will be exposure during
the window ofsensitivity. Thus, postspermatogonial stem
cell induced mutations are of significance in assessing
genetic/reproductive/developmental risk.
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